Novaquest Capital Management

Private Equity SEC-registered adviser

Legal name: Novaquest Capital Management, L.L.C.

Website LinkedIn

AUM

$1.5B
Regulatory AUM

Private funds

13
Private Equity 13

Private fund assets

$1.6B
Gross asset value

Employees

18

Last Form D raise

Jun 2024
Most recent fund filing

From SEC Form ADV filing (filed Mar 31, 2026). View on SEC

People(6)

Owners and executive officers named on the firm's SEC Form ADV.

B
Bryan Mills
Member, Chief Administrative Officer, Management Committee Member
Source: SEC Form ADV
E
Ernest Brown
Management Committee Member
Source: SEC Form ADV
M
Michael Bologna
Member, Chief Investment Officer, Management Committee Member
Source: SEC Form ADV
P
Patrick Jordan
Member, Managing Partner, Management Committee Member
Source: SEC Form ADV
R
Robert Hester
Member, Chief Financial Officer, Executive Vice President
Source: SEC Form ADV
Y
Yoshitaka Oshiba
Management Committee Member
Source: SEC Form ADV

Funds(13)

Private funds reported on Form ADV, with amounts raised from the funds' SEC Form D filings.

FundTypeGross assetsRaised (Form D)InvestorsLast Form DRecency
Novaquest Pharma Opportunities Fund VI, L.P.Private Equity$73.9M$90.0M2Jun 2024Cold
Novaquest Animal Health Opportunities Fund (delaware), L.P.Private Equity$140.8M$80.6M1Jun 2023Cold
Novaquest Animal Health Opportunities Fund, L.P.Private Equity$10.3M$80.6M1Jun 2023Cold
Novaquest Pharma Opportunities Fund V, L.P.Private Equity$603.4M$892.8M13Jun 2019Cold
Novaquest Pharma Opportunities Fund V (delaware), L.P.Private Equity$376.7M$892.8M1Jun 2019Cold
Novaquest Co-Investment Fund VI, L.P.Private Equity$32.1M$25.0M2Jul 2017Cold
Novaquest Pharma Opportunities Fund IV (co-Invest), L.P.Private Equity$53.2M$75.0M1Dec 2015Cold
Novaquest Pharma Opportunities Fund IV (parallel), L.P.Private Equity$13.8M$75.0M1Dec 2015Cold
Novaquest Pharma Opportunities Fund IV, L.P.Private Equity$125.7M——Jun 2015Cold
Novaquest Pharma Opportunities Fund IV Aggregator, L.P.Private Equity$72.9M———
Nqp Aiv I, L.P.Private Equity$50.9M———
Novaquest Pharma Opportunities Fund IV (co-Invest-A), L.P.Private Equity$8.3M———
Novaquest Pharma Opportunities Fund IV (co-Invest-A), L.P.Private Equity$2.2M———

Board seats

Companies whose SEC Form D filings name one of this firm's people as a director, matched by name and office ZIP code.

No board seats matched from SEC filings yet.

Regulatory identifiers

CRD number
160359
SEC file number
801-73992

Sources